Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis

Epidemiological Study About the Clinical and Microbiological Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis.

To determine proportion of women achieving clinical and mycological cure or have recurrences / reinfection after being treated for an acute episode of vulvovaginal candidiasis.

Inclusion Criteria:

• Sexually active women between 18 and 50 years
• Patients attending to the gynecologist with acute vulvovaginal candidiasis.
• Patients requiring standard treatment with clotrimazole 500 single dose and that the decision to prescribe this treatment is prior to inclusion in the study.
• Women who agree to participate in the study and has signed the informed consent sheet.

Exclusion Criteria:

• Use of any medication that may interfere significantly with study assessments.
• Pregnant or breastfeeding
• Women with signs of other genital infection
• Within 3 months after childbirth or abortion
• Patients that is expected not to attend follow-up visits